We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ESLA market cap is 30.02M. The company's latest EPS is USD -0.1224 and P/E is -6.78.
| Quarter End | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 0 | -470k | -3.95M | -3.38M | -2.1M |
| Net Income | 139k | -470k | -3.95M | -3.38M | -2.1M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -249k | -1.57M | -11.11M | -7.31M | -4.43M |
| Net Income | -248k | -996k | -11.11M | -7.31M | -4.43M |
| Quarter End | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 27.35M | 8.63M | 4.45M | 3.74M | 2.44M |
| Total Liabilities | 17.28M | 138k | 181k | 2.99M | 4.28M |
| Total Equity | 10.07M | 8.5M | 4.27M | 746k | -1.83M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 45.8M | 9.72M | 3.03M | 4.45M | 3.14M |
| Total Liabilities | 1.62M | 2.65M | 9.77M | 181k | 3M |
| Total Equity | -1.01M | -2.26M | -11.74M | 4.27M | 144k |
| Quarter End | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | -15.78M | -16.07M | -2.22M | -466k |
| Investing | N/A | 4.96M | 4.96M | N/A | N/A |
| Financing | N/A | 13.06M | 12.79M | -150k | -30k |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -316k | -1.04M | -1.34M | -16.07M | N/A |
| Investing | -45.19M | 36.17M | N/A | 4.96M | N/A |
| Financing | 45.98M | -35.56M | -273k | 12.79M | N/A |
| Market Cap | 30.02M |
| Price to Earnings Ratio | -6.78 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 32.68 |
| Price to Book Ratio | 208.45 |
| Dividend Yield | - |
| Shares Outstanding | 36.17M |
| Average Volume (1 week) | 16.93k |
| Average Volume (1 Month) | 15.55k |
| 52 Week Change | -36.64% |
| 52 Week High | 3.23 |
| 52 Week Low | 0.63 |
| Spread (Intraday) | 0.03 (3.49%) |
| Company Name | Estrella Immunopharma Inc |
| Address |
108 w. 13th street wilmington, delaware 19801 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
